Securities Code: 300401
Bond Code: 123178
Securities Abbreviation: Huayuan Bio
Bond Abbreviation: Huayuan Convertible Bond
Announcement Number: 2026-035
Zhejiang Huayuan Bio-Pharmaceutical Co., Ltd.
Announcement Regarding the Expected Trigger of the Redemption Condition for Huayuan Convertible Bonds
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or significant omissions.
Special Reminder:
From June 22, 2026, to July 3, 2026, the closing price of Zhejiang Huayuan Bio-Pharmaceutical Co., Ltd. ("the Company") stock has been no less than 130% of the current conversion price of RMB 13.34 per share (i.e., RMB 17.34 per share) for 10 trading days. If the closing price of the Company's stock continues to be no less than 130% of the current conversion price (including 130%, i.e., RMB 17.34 per share), it is expected that the conditional redemption clause of "Huayuan Convertible Bond" may be triggered.
According to the conditional redemption clause in the "Prospectus for the Offering of Convertible Corporate Bonds to Non-specific Targets" of Zhejiang Huayuan Bio-Pharmaceutical Co., Ltd. (hereinafter referred to as the "Prospectus"), during the conversion period of the convertible corporate bonds issued (hereinafter referred to as "convertible bonds"), if the closing price of the Company's stock is no less than 130% of the current conversion price (including 130%) for at least fifteen trading days within any consecutive thirty trading days, the Company has the right to redeem all or part of the unexercised convertible bonds at the price of the bond face value plus accrued interest.
If the conditional redemption clause is triggered, the Company will fulfill the subsequent deliberation procedures and information disclosure obligations in a timely manner according to relevant regulations. We kindly remind investors to pay close attention to subsequent announcements from the Company and be aware of investment risks.
I. Basic Information of Convertible Corporate Bonds
- Issuance of Convertible Corporate Bonds
Approved by the China Securities Regulatory Commission (CSRC) Document No. [2023] 252, the Company issued 12 million convertible bonds to non-specific targets on March 6, 2023. Each bond has a face value of RMB 100, and the total issuance amount is RMB 1.2 billion.
- Listing of Convertible Bonds
Approved by the Shenzhen Stock Exchange, the Company's 12 million convertible bonds were listed and traded on the Shenzhen Stock Exchange from March 23, 2023. The bond abbreviation is "Huayuan Convertible Bond" and the bond code is "123178".
- Conversion Period of Convertible Bonds
According to the "Prospectus," the conversion period for the convertible bonds issued by the Company is from September 3, 2023, to March 5, 2029.